undec-2-ene-2-carboxylate, was synthesized starting from an acetoxyazetidinone chiron 6 in a practical manner based on a C-C bond formation reaction between 6 and piperidinone-ester 5, palladium-catalyzed de(allyloxy)carbonylation of 7b and Wittig-type cyclization via an oxalimide 9. Selective deprotection of the N-Boc group of 2 was found to proceed smoothly by treatment with trimethylsilyl trifluoromethanesulfonate and 2,6-lutidine to give the amino compound 3, whose functionalization on the nitrogen atom to derivatives 10 followed by deprotection led to various 5-azatrinem acids 4. These compounds showed potent in vitro activities against gram-positive and gram-negative bacteria.
Since the discovery of thienamycin in 1976 by the Merck research group, 1) a huge number of carbapenem derivatives have been synthesized with the development of new synthetic methodologies for seeking potent antibacterial agents.
2) With the growing concern over the emergence of antibiotic-resistant bacteria, some structurally unique carbapenem analogs have been explored to overcome this serious problem. For this goal, tricyclic carbapenems (referred to as trinems), such as Sanfetrinem, which has a fused cyclohexane ring possessing a 4a-methoxy substituent (Fig. 1 , XϭOCH 3 ), were reported by the Glaxo Wellcome research group.
3) In a further study of the trinem series, 4) some thia-or oxa-analogs containing a sulfur or an oxygen atom in the cyclohexane ring, that is 4-, 6-and 7-thia-trinem, or 5-and 7-oxo-analogs have also been synthesized and their antibacterial activities have been reported. 5) However, there have been no reports on the corresponding aza-analog. 6) We were particularly interested in 5-azatrinems, because there were only a few reports on 5-substituted trinem derivatives 7) and introduction of a nitrogen atom at the 5-position is convenient for modifying the molecule at this position. Therefore our principal aim in this project was to develop an efficient synthetic route to 5-azatrinems and to evaluate these compounds as possible antibacterial agents.
Here we report a stereocontrolled synthesis of a piperidine-condensed tricyclic key intermediate 2 which is suitable via 3 for modification on the nitrogen atom, its subsequent derivatization to a variety of 5-azatrinems 4 and their in vitro antibacterial activities.
Synthesis Analysis of our target structure led us to prepare a 3-azacyclohexanone derivative 1, which has the same configuration at the C-8 position as trinem, utilizing a stereocontrolled decarboxylation reaction of a b-ketoester 7b according to a literature procedure. 8) A coupling reaction of the commercially available acetoxyazetidinone 6 with the sodium salt of allyl b-ketoester 5, which was provided by the transesterification reaction of the corresponding ethyl ester with sodium allyloxide in allyl alcohol, in tetrahydrofuran (THF) gave a 3 : 2 mixture of two diastereoisomers 7a in quantitative yield. After protecting the NH group of 7a by treatment with tert-butyldimethylsilyl triflate (TBSOTf) and 2,6-lutidine in dichloromethane (CH 2 Cl 2 ), the product 7b was subjected to the stereocontrolled decarboxylation reaction in the presence of triethylamine (Et 3 N), formic acid and a catalytic amount of tetrakis(triphenylphosphine)palladium(0) in ethyl acetate (EtOAc).
9) The reaction occurred readily at 0°C to afford the ketone 8a with desired stereochemistry 10) in 77% yield from 7a. The ketone 8a was not stable enough, probably due to its basicity, to store for weeks in a refrigerator even in a crystalline form. Therefore, the Nbenzyl group was exchanged to the N-tert-butoxycarbonyl (N-Boc) group as follows. Hydrogenolysis of 8a using 10% Pd-charcoal under a hydrogen atmosphere in EtOAc in the presence of di-tert-butyl dicarbonate (Boc 2 O) gave a quantitative yield of 8b. The ketone 8b was stable in cold storage, but it was found to be sensitive to silica gel, on which chromatography brought about partial epimerization at the a-position of the ketone group. This epimerization was also observed in the next reaction to deprotect the N-TBS group of 8b. The results of N-desilylation of 8b with tetrabutylammo-nium fluoride (TBAF) in the presence of various acids are summarized in Table 1 . Treatment of 8b with TBAF (1 eq) in the presence of AcOH (1 eq) in THF (run 2) gave a 1 : 1 mixture of 1 and its epimer 1. Use of excess acid retarded the epimerization. Hydrogen fluoride gave better results than organic acids. The best result was obtained by using a combination of TBAF (1 eq) and HCl (1 eq) to give a 10 : 1 ratio of 1 : 1 (run 7).
The ketone 1 also isomerized during silica gel chromatography. Fortunately, the crude product crystallized without chromatography and it could be purified by recrystallization from hexane to afford the pure ketone 1 in 66% yield in two steps from 8a, which was found to be stable during storage at room temperature. The ketone 1 could be transformed to the piperidine-condensed tricyclic compound 2 in a conventional manner via an intramolecular Wittig-type reaction 11) as follows. Treatment of 1 with allyloxyoxalyl chloride in the presence of Et 3 N in CH 2 Cl 2 afforded the oxalimide 9, which was then heated with excess triethyl phosphite in toluene at 60°C for 3 h. The ylide formation and subsequent cyclization occurred simultaneously at this temperature and the pure crystals of 2 were obtained in 67% yield by recystallization of the crude product. The stereochemistry at the C8 position of 2 was confirmed by nuclear Overhauser effect (NOE) experiment. The NOEs were observed between 8-H and 9-H, and 7-H and 10-H, respectively.
With the precursor 2 of 5-azatrinem derivatives in hand, we investigated the selective deprotection of its N-Boc group to provide the NH compound 3. The 5-azatrinem skeleton could not survive under the usual acidic conditions to deprotect the N-Boc group. Recently, TBSOTf/2,6-lutidine or trimethylsilyl triflate (TMSOTf)/2,6-lutidine has been reported as an efficient reagent for chemoselective removal of the N-Boc group. 12) We applied this procedure to our sensitive compound. Treatment of 2 with 1.2 eq of TMSOTf in the presence of 2,6-lutidine (1.2-1.5 eq) in CH 2 Cl 2 at 0°C to room temperature for 10-15 min and subsequent aqueous workup afforded a free piperidine derivative 3 in quantitative yield. This amine was not stable. So, it was immediately transformed to a variety of N-modified precursors 10 for azatrinems such as amides, amines, ureas, thiourea, and amidines by reaction with various electrophiles as shown in a) The ratio was determined by 1 H-NMR spectrum of the crude product.
Chart 4. The amide-type precursors 10a-e, g, h were synthesized by treatment of 3 with the corresponding acid chloride or acylimidazolide. A precursor 10i for unsubstituted 5-azatrinem 4i (RϭH) was obtained by reaction of 3 with allyl chloroformate. 3-Guanidinopropionyl derivative 10f was prepared from 10e as follows (Chart 5). The N-Boc group of 10e was removed by use of the above mentioned TMSOTf/2,6-lutidine combination and subsequent treatment with N,NЈ-bis(allyloxycarbonyl)amidinopyrazole 13) afforded 10f. N-Alkylation of 3 with alkyl iodide in the presence of triethylamine or potassium carbonate afforded the tertiary amines 10j, k. The ureas 10l, n were synthesized by treatment of 3 with trimethlysilyl isocyanate and 3-isocyanato-NAoc-pyrrolidine, respectively. On the other hand, 10m was prepared by reaction of the piperidine 3 with triphosgene, followed by treatment with N-Aoc-guanidine, in the presence of 4-dimethylaminopyridine (DMAP). The thioureas 10o, p were synthesized by treatment of 3 with isothiocyanates, which were prepared by reaction of 1,1Ј-thiocarbonyldiimidazole and primary amines. The amidine precursor 10r and guanidine precursor 10s were synthesized by treatment of 3 with N-(allyloxycarbonyl)acetamidine hydrochloride and N,NЈ-bis(allyloxycarbonyl)amidinopyrazole, respectively.
The 5-azatrinem precursors 10 thus obtained could be transformed to the fully deprotected acids 4 in 2 steps. Firstly, the TBS protecting group of 10 was removed by treatment with NH 4 F HF in a 1 : 1 mixture of N,NЈ-dimethylformamide (DMF) and N-methylpyrrolidinone 14) to give the alcohols 11 in moderate yields. Then, the allyl ester group and/or N-allyloxycarbonyl group(s) in the side chain of 11 were deprotected by Pd(0) catalyzed deallylation reaction 15) in the presence of a suitable allyl scavenger such as dimedone, potassium 2-ethylhexanoate or n-butyltin hydride to give the piperidine-condensed tricyclic carbapenems 4 (Chart 6). Amidines 4e and 4q were prepared by formimidoylation of the amines 4d and 4i, respectively, with excess benzyl formimidate hydrochloride in a buffered aqueous acetonitrile in the presence of N,NЈ-diisopropylethylamine.
Biological Properties The in vitro antibacterial activities (minimal inhibitory concentrations (MICs)) of these 5-azatrinems (4a-s) are shown in Table 2 . Among amide-type derivatives 4a-h, 5-acetyl derivative 4a has reasonable antibacterial potency, although its activity was generally weaker than Sanfetrinem. The pyridylcarbonyl compounds 4g, h showed decreased activity. Introduction of the amino, amidino or guanidino function on the acyl side chain as shown such as glycine and b-alanine analogs 4b-f improved potency against both gram-positive and -negative bacteria. But they have weak activity against Proteus vulgaris, Morganella morganii and methicillin-resistant-staphylococcus aureus (MRSA). The simple amines 4i and 4j, whose nitrogen atom in the piperidine ring is basic, showed less antibacterial activity than glycine and b-alanine analogs 4b-f. The tert-amine derivative 4k with the methyl group modified by the carbamoyl group recovered some antibacterial activities in contrast to 4j, probably due to the hydrophilic property of the carbamoyl group and increased stability of the compound coming from the decreased basicity by attaching the electron-withdrawing group. In a series of urea and thiourea compounds 4l-p, the simple urea 4l and the guani- 12.5 Ͼ100 Ͼ100 25 100 Ͼ100 Ͼ100 50 Ͼ100 Ͼ100 Ͼ100 3.1 6.2
a)
MIC was determined by the agar dilution method with an inoculum of 10 dinocarbonyl derivative 4m exhibited potent and broad-spectrum activity comparable to Sanfetrinem. None of these azatrinems showed any interesting antibacterial activity against Pseudomonas aeruginosa. The amidine and guanidine derivatives 4q-s showed a good potency against gram-positive and -negative bacteria. In particular, the formamidine 4p and guanidine 4s expressed high activity with a well-balanced spectrum including activity against P. aeruginosa. This antipseudomonal activity supports the hypothesis that a positively charged functional group facilitates the penetration of b-lactams into Pseudomonas spp. 4) In order to estimate the biological stability of the 5-azatrinem, urinary recovery of the formimidoyl compound 4q was determined by subcutaneous administration to mice. Forty-seven percent of the 5-formimidoyl-5-azatrinem 4q was recovered in urine.
Conclusion
The convenient 5-azatrinem precursor 2 was synthesized starting from an acetoxyazetidinone 6 in a practical manner based on stereocontrolled palladium-catalyzed de(allyloxy)-carbonylation and Wittig-type cyclization via an oxalimide 9. Selective deprotection of the N-Boc group of 2 by treatment with TMSOTf and 2,6-lutidine to give the amino compound 3, whose functionalization on the nitrogen atom to derivatives 10 followed by deprotection led to various 5-azatrinem analogs 4. In the course of our study for seeking 5-azatrinem derivatives that show potent antibacterial activities, we found 5-amidino-type compounds that possessed potent in vitro activities against gram-positive and -negative bacteria.
Experimental
Melting points are uncorrected. 1 H-NMR spectra were recorded on a JEOL JNM-EX-270 (270 MHz) or a JEOL JNM-GX-270 (270 MHz) spectrometer and 13 C-NMR spectra were recorded on a JEOL JNM-GSX-400 (100 MHz) spectrometer. Chemical shifts are shown in ppm downfield from internal tetramethylsilane in CDCl 3 or sodium 2,2-dimethyl-2-silapentane-5-sulfonate in D 2 O. The abbreviations used in the 1 H-NMR data are as follows: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; dq, doublet of quartets; br, broad; m, multiplet. Infrared (IR) spectra were recorded on a JASCO A-102, FT/IR-8300 or FT/IR-8900 spectrometer. Optical rotations were measured on a Perkin-Elmer 141 spectrometer at 25°C. Mass spectra (MS) were obtained on a JEOL JMS-D300 or JMS-AX505H spectrometer. Chromatography columns were prepared with Silica gel 60 (230-400 mesh, E. Merck) or Cosmosil 75C 18 -PREP (Nacalai Tesque). High pressure liquid chromatography (HPLC) was performed on an LC-908 (Japan Analytical Industry Co., Ltd.) with joined two GPC columns in succession (a JAIGEL-1H (20 mm i.d.ϫ600 mm) and a JAIGEL-2H (20 mm i.d.ϫ600 mm)).
N-(Allyloxycarbonyl)amino Acids N-(allyloxycarbonyl)amino acids were prepared from the corresponding amino acids following the literature procedure.
15d) The preparation of 3-(allyloxycarbonylamino)propionic acid is described below as a typical example. To a solution of 3-aminopropionic acid (5.0 g, 5.6ϫ10
Ϫ2 mol) in a mixture of H 2 O-THF (2 : 1, 90 ml) were added a solution of allyl chloroformate (5.9 ml, 5.6ϫ10 Ϫ2 mol) in THF (30 ml) and 2 N NaOH (56 ml) at room temperature. After being stirred for 1 h, the mixture was concentrated under reduced pressure to ca. 30 ml and then acidified to ca. pH 2 by addition of 2 N HCl. The product was extracted with EtOAc. The extract was dried and concentrated under reduced pressure to give 3-(allyloxycarbonylamino)propionic acid (9.68 g) as a colorless oil in quantitative yield. 1 Ϫ2 mol) in allyl alcohol (200 ml), with stirring at 0°C, and the mixture was heated under reflux for 10 h. After being cooled, the reaction mixture was slowly poured into ice-cold 1 N HCl (200 ml), and then neutralized by addition of a saturated aqueous solution of NaHCO 3 . The product was extracted with EtOAc, and the extract was washed with brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (400 g) using a mixture of hexane and EtOAc (5 : 1) as eluent to give 5 (14.2 g, 62%) as a pale yellow oil. 98 mmol) in THF (150 ml) was added. After being stirred at 0°C for 30 min, the mixture was partitioned between a diluted aqueous solution of ammonium chloride (100 ml) and EtOAc (50 ml). The organic layer was separated, washed with brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (400 g) using a mixture of hexane and EtOAc (3 : 1) as eluent, to give 7a (37.0 g, 99%) as a colorless oil which was shown by 1 H-NMR spectrum to be a 3 : 2 mixture of two diastereoisomers.
Major Ϫ2 mol) and 2,6-lutidine (18.9 ml, 8.25ϫ10
Ϫ2 mol) in CH 2 Cl 2 (250 ml) was added TBSOTf (9.7 ml, 8.3ϫ10 Ϫ2 mol) at 0°C. After being stirred for 10 min, water and a mixture of EtOAc and hexane (4 : 1, 750 ml) were added to the reaction mixture. The organic layer was separated, washed with a saturated aqueous solution of NaHCO 3 , a saturated aqueous solution of NH 4 Cl and brine, successively, and dried. After evaporation of the solvent, the crude product was subjected to chromatography on silica gel (400 g) using a mixture of hexane and EtOAc (4 : 1) as eluent, to give the N-TBS-protected product 7b as a colorless oil (47 g). A solution of 7b in EtOAc (250 ml) was added to a mixture of tetrakis(triphenylphosphine)palladium (867 mg, 7.50ϫ10 Ϫ4 mol), triphenylphosphine (984 mg, 3.75ϫ10 Ϫ3 mol), Et 3 N (36.7 ml, 2.63ϫ10 Ϫ1 mol) and formic acid (8.49 ml, 2.25ϫ10 Ϫ1 mol) in EtOAc (300 ml) at 0°C. The mixture was stirred at the same temperature for 2.5 h, diluted with hexane (200 ml), and washed with a saturated aqueous solution of NH 4 Cl (200 mlϫ3), water (200 ml), and brine (200 mlϫ2), dried, and concentrated under reduced pressure. The residue was subjected to flash chromatography on silica gel (1.2 kg) using a mixture of ethyl acetate and hexane (1 : 5 to 1 : 1) as eluent to give the product 8a (30.1 g, 77%) as pale yellow crystals, mp 96-99°C. Ϫ2 mol), successively, at Ϫ78°C. After being stirred at 0°C for 10 min, the mixture was quenched with phosphate buffer and extracted with EtOAc (400 ml). The extract was washed with water, a saturated aqueous solution of NaHCO 3 , a saturated aqueous solution of NH 4 Cl and brine, successively. The organic layer was dried and concentrated under reduced pressure to give 9 as an oil. . This crude oil was dissolved in toluene (4 ml) and triethyl phosphite (12 ml) was added, and the whole was heated at 60°C for 3 h. After removal of excess triethyl phosphite and solvent under reduced pressure, the residue was subjected to column chromatography on silica gel (100 g) using a mixture of hexane and EtOAc (4 : 1) as eluent. The eluate was concentrated under reduced pressure to give a pale yellow oil, which was crystallized from hexane to give 2 (3.03 g, 67%) as colorless crystals, mp 86-89°C. Ϫ3 mol) and 2,6-lutidine (206 ml, 1.77ϫ10 Ϫ3 mol) in CH 2 Cl 2 (6 ml) was added TMSOTf (284 ml, 1.47ϫ10
Ϫ3 mol) at 0°C. After being stirred at the same temperature for 15 min, a saturated aqueous solution of NaHCO 3 was added and the mixture was extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure to give 3 (440 mg, 91%) as a pale yellow oil, which was immediately used for the next reaction without further purification due to its instability. ]undec-2-ene-2-carboxylate (10a) To a solution of the above-mentioned crude product 3 (217 mg, 5.34ϫ10
Ϫ4 mol) and Et 3 N (117 ml, 0.84ϫ10 Ϫ4 mol) in CH 2 Cl 2 (2.5 ml) was added acetyl chloride (57 ml, 8.0ϫ10
Ϫ4 mol) at 0°C. After being stirred for 15 min, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl, a saturated aqueous solution of NaHCO 3 , and then brine. The organic layer was dried and concentrated under reduced pressure. The residue was subjected to HPLC using CHCl 3 as eluent to afford 10a (208 mg, 87%) a colorless crystals, mp 49-54°C. Ϫ4 mol) in a manner similar to that described above, in CH 2 Cl 2 (0.5 ml) was added to a mixture of 1,1Ј-carbonyldiimidazole (CDI, 101 mg, 6.20ϫ10 Ϫ4 mol) and N-(allyloxycarbonyl)glycine 13d) (98.2 mg, 6.17ϫ10 Ϫ4 mol) in CH 2 Cl 2 (3 ml) at 0°C. After being stirred at the same temperature for 15 min, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl, a saturated aqueous solution of NaHCO 3 , and then brine. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (8 g) using a mixture of EtOAc and hexane (1 : 1) as eluent to give 10b (138 mg, 51%) as a colorless viscous oil. Ϫ4 mol) in a manner similar to that described above, in CH 2 Cl 2 (2 ml) was added to a mixture of CDI (178 mg, 1.10ϫ10
Ϫ3 mol) and 3-(allyloxycarbonylamino)propionic acid (190 mg, 1.10ϫ10 Ϫ3 mol) in CH 2 Cl 2 (1.5 ml) at 0°C. After being stirred at the same temperature for 20 min, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl, a saturated aqueous solution of NaHCO 3 , and then brine. The organic layer was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (12 g) using a mixture of EtOAc and hexane (1 : 1) as eluent to give 10c (227 mg, 55%) as a colorless viscous oil. Ϫ3 mol) in a manner similar to that described above, in DMF (8 ml) was added to a mixture of CDI (899 mg, 5.54ϫ 10 Ϫ3 mol) and N-allyloxycarbonylsarcosine (870 mg, 5.02ϫ10 Ϫ3 mol) in DMF (17 ml) at 0°C. After being stirred at room temperature for 6 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl, a saturated aqueous solution of NaHCO 3 , and then brine. The organic layer was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (80 g) using a mixture of EtOAc and hexane (3 : 2) as eluent to give 10d (1.60 g, 71%) as a pale yellow viscous oil. 1 Ϫ3 mol) in a manner similar to that described above, in DMF (4 ml) was added to a mixture of CDI (288 mg, 1.78ϫ10
Ϫ3 mol) and 3-(tert-butoxycarbonylamino)propionic acid 16) (336 mg, 1.78ϫ10 Ϫ3 mol) in DMF (2 ml) at 0°C. After being stirred at the same temperature for 3 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl, a saturated aqueous solution of NaHCO 3 , and then brine. The organic layer was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (15 g) using a mixture of EtOAc and hexane (1 : 1) 
N,N-Bis(allyloxycarbonyl)amidinopyrazole
This reagent was prepared following the literature procedure for the preparation of N,NЈ-bis(tertbutoxycarbonyl)amidinopyrazole. 13) To a suspension of amidinopyrazole hydochloride (6.00 g, 40.9 mmol) in DMF-THF (1 : 1, 60 ml) were added allyl chloroformate (4.55 ml, 43 mmol) and Et 3 N (11.8 ml, 85 mmol) at 0°C. After being stirred at room temperature for 3 h, the mixture was diluted with EtOAc (100 ml) and washed with water, a saturated aqueous solution of NH 4 Cl and brine, successively. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (200 g) using a mixture of EtOAc and hexane (1 : 1) as eluent to give N-(allyloxycarbonyl)amidinopyrazole (7.02 g, 90%) as a colorless oil. To a solution of this oil (4.60 g, 27.7 mmol) in THF (100 ml) was added sodium hydride (55% mineral oil dispersion, 2.55 g, 58.4 mmol, washed with hexane) at 0°C. After being stirred at room temperature for 30 min, a solution of diallyl dicarbonate (5.6 g, 30 mmol) in THF (10 ml) was added at 0°C and the mixture was stirred at room temperature for 1.5 h. The reaction mixture was quenched with a saturated aqueous NH 4 Cl solution and extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (350 g) using a mixture of EtOAc and hexane (2 : 1) as eluent to give N,NЈ-bis(allyloxycarbonyl)amidinopyrazole (5.4 g, 70%) as a colorless oil. Ϫ4 mol) and 2,6-lutidine (294 ml, 2.52ϫ10 Ϫ3 mol) in CH 2 Cl 2 (6 ml) was added TMSOTf (352 ml, 1.82ϫ10
Ϫ3 mol) at 0°C. After being stirred at room temperature for 15 min, the mixture was quenched with a saturated aqueous solution of NaHCO 3 , and extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure. The residue was dissolved in THF (3 ml), and a solution of N,NЈ-bis(allyloxycarbonyl)amidinopyrazole (234 mg, 8.40ϫ10 Ϫ4 mol) in THF (2 ml) was added at room temperature. After being stirred at the same temperature for 15 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl and brine. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to HPLC using CHCl 3 as eluent to give 10f (203 mg, 35%) as a pale yellow viscous oil. 1 Ϫ4 mol) in a manner similar to that described above, in CH 2 Cl 2 (3 ml) was added Et 3 N (179 ml, 1.28ϫ10
Ϫ3 mol) and nicotinoyl chloride hydrochloride (114 mg, 6.40ϫ10
Ϫ4 mol) at 0°C. After being stirred at the same temperature for 30 min, the mixture was poured into phosphate buffer (pH 7.4, 10 ml) and extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure to give an oily residue, which was purified by column chromatography on silica gel (8 g) using a mixture of EtOAc and methanol (1 : 0 to 9 : 1) as eluent to afford 10g (207 mg, 79%) as a pale yellow viscous oil. 1 Ϫ4 mol) in a manner similar to that described above, in DMF (0.5 ml) was added to a mixture of CDI (192 mg, 1.18ϫ10
Ϫ3 mol) and isonicotinic acid (152 mg, 1.24ϫ10 Ϫ3 mol) in DMF (4 ml) at 0°C. After being stirred at the same temperature for 35 min, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl, a saturated aqueous solution of NaHCO 3 , and then brine. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (15 g) using a mixture of EtOAc and methanol (1 : 0 to 9 : 1) as eluent to give 10h (350 mg, 69%) as a colorless viscous oil. Ϫ4 mol) and 2,6-lutidine (86 ml, 7.4ϫ10 Ϫ4 mol) in CH 2 Cl 2 (2.5 ml) was added TMSOTf (118 ml, 6.11ϫ10
Ϫ4 mol) at 0°C. After being stirred at room temperature for 15 min, the mixture was cooled at 0°C, and a saturated aqueous solution of NaHCO 3 (25 ml) was added. Stirring was continued for 15 min, then, Et 3 N (86 ml, 6.2ϫ10 Ϫ4 mol) and allyl chloroformate (65 ml, 6.2ϫ10 Ϫ4 mol) were added at 0°C, and the whole was stirred for 10 min. The mixture was diluted with EtOAc, washed with a saturated aqueous solution of NH 4 Cl, a saturated aqueous solution of NaHCO 3 , and then brine. The organic layer was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (8 g) using a mixture of EtOAc and hexane (1 : 1) as eluent to give 10i (198.9 mg, 82%) as a colorless oil. ]undec-2-ene-2-carboxylate (10j) To a solution of 3, freshly prepared from 2 (300 mg, 5.92ϫ10
Ϫ4 mol) in a manner similar to that described above, in DMF (2 ml) were added Et 3 N (420 ml, 3.0ϫ10
Ϫ3 mol) and a solution of iodomethane (170 mg, 1.20ϫ10 Ϫ3 mol) in DMF (0.5 ml) at 0°C. After being stirred at the same temperature for 1 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NaHCO 3 and brine. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (25 g) using a mixture of EtOAc and methanol (95 : 5) as eluent to give 10j (97.8 mg, 39%) as a pale yellow viscous oil. 1 Ϫ3 mol) in a manner similar to that described above, in DMF (5 ml) were added K 2 CO 3 (138 mg, 1.00ϫ10 Ϫ3 mol) and 2-iodoacetamide (925 mg, 5.00ϫ10
Ϫ3 mol) at room temperature. After being stirred at the same temperature for 1 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl and brine. The organic layer was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (20 g) using a mixture of EtOAc and methanol (1 : 0 to 10 : 1) as eluent to give 10k (416 mg, 90%) as a colorless viscous oil. 1 Ϫ4 mol) in a manner similar to that described above, in CH 2 Cl 2 (3 ml) was added trimethylsilyl isocyanate (117 ml, 8.64ϫ10
Ϫ4 mol) at 0°C. After being stirred at the same temperature for 1 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (8 g) using a mixture of EtOAc and methanol (1 : 0 to 95 : 5) as eluent and then HPLC using CHCl 3 as eluent to give 10l (135.5 mg, 61%) as a colorless viscous oil. 
N-(Allyloxycarbonyl)guanidine
To a solution of guanidine hydrochloride (2.00 g, 20.9 mmol) in a mixture of H 2 O and THF (3 : 1, 40 ml) were added 2 N NaOH (21 ml) and a solution of allyl chloroformate (2.53 g, 21.0 mmol) in THF (10 ml) at room temperature. After being stirred for 1 h, the mixture was concentrated under reduced pressure to ca. 40 ml. The resultant precipitates that emerged were sparingly soluble in water and removed by filtration. The filtrate was further concentrated under reduced pressure to ca. 5 ml. The resultant solids which were water-soluble were collected by filtration and washed with cold water to give N-(allyloxycarbonyl)guanidine (682 mg, 23%) as colorless crystals, mp 137-139°C. Ϫ4 mol) in a manner similar to that described above, and N,NЈ-diisopropylethylamine (160 ml, 9.19ϫ10 Ϫ4 mol) in CH 2 Cl 2 (5 ml) were added to a solution of triphosgene (90.0 mg, 3.03ϫ10 Ϫ4 mol) in CH 2 Cl 2 (1 ml) at 0°C. After being stirred at the same temperature for 30 min, DMAP (108 mg, 8.84ϫ10
Ϫ4 mol) and (allyloxycarbonyl)guanidine (160 mg, 1.12ϫ10 Ϫ3 mol) were added and the mixture was stirred at 0°C for 2 h. The mixture was diluted with EtOAc and washed with a saturated aqueous solution of NaHCO 3 and brine. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (15 g) using a mixture of EtOAc and hexane (2 : 3) as eluent to give 10m (187 mg, 31%) as a pale yellow viscous oil. 
3-Amino-1-(allyloxycarbonyl)pyrrolidine Hydrogen Chloride
To a solution of 3-(tert-butoxycarbonylamino)pyrrolidine (1.86 g, 10.0 mmol) in CH 2 Cl 2 (20 ml) was added Et 3 N (1.46 ml, 10.5 mmol) and allyl chloroformate (1.11 ml, 10.5 mmol) at 0°C. After being stirred at the same temperature for 1 h, a saturated aqueous solution of NH 4 Cl was added and extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure. The residue was dissolved in EtOAc (10 ml) and treated with 4 N HCl in EtOAc (5 ml) at room temperature. A pale yellow oil that emerged was separated by decantation and dried under reduced pressure. 3-Amino-1-(allyloxycarbonyl)pyrrolidine hydrogen chloride (2.08 g, ca. 100%) thus obtained as a pale yellow oil was used for the next reaction without further purification. Ϫ4 mol) in a manner similar to that described above, in CH 2 Cl 2 (1 ml) was added a solution of 3-isocyanato-1-(allyloxycarbonyl)pyrrolidine, which was prepared from 3-amino-1-(allyloxycarbonyl)pyrrolidine hydrogen chloride (42 mg, 2.0ϫ10 Ϫ4 mol) and triphosgene (20 mg, 6.7ϫ10 Ϫ5 mol) in the presence of ethyldiisopropylamine (90 ml, 5.0ϫ10 Ϫ4 mol) in CH 2 Cl 2 (2 ml), at room temperature. After being stirred at the same temperature for 30 min, a saturated aqueous solution of NaHCO 3 was added and the mixture was extracted with EtOAc. The extract was washed with a saturated aqueous solution of NH 4 Cl and brine, dried and concentrated under reduced pressure. After removal of solvent under reduced pressure, the residue was subjected to column chromatography on silica gel (10 g) using EtOAc as eluent to give 10n (90.4 mg, 76%) as a colorless viscous oil. Ϫ4 mol) in a manner similar to that described above, in CH 2 Cl 2 (2 ml) was added methyl isothiocyanate (73 mg, 1.0ϫ10
Ϫ3 mol) at room temperature. After being stirred at the same temperature for 1 h. The mixture was concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (10 g) using a mixture of EtOAc and hexane (2 : 1) as eluent to give 10o (196 mg, 81%) as a colorless viscous oil. 
1-(Allyloxycarbonyl)pyrrolidin-3-yl Isothiocyanate
To a solution 3-amino-1-(allyloxycarbonyl)pyrrolidine (870 mg, 5.1 mmol), which was provided by neutralization of 3-amino-1-(allyloxycarbonyl)pyrrolidine hydrogen chloride by treatment with an aqueous solution of NaHCO 3 , in CH 2 Cl 2 (8 ml) was added 1,1Ј-thiocarbonyldiimidazole (1.00 g, 5.61 mmol) at Ϫ78°C. After being stirred at 0°C for 3 h, phosphate buffer (pH 7, 20 ml) was added and the mixture was extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (30 g) using a mixture of EtOAc and hexane (1 : 1) as eluent to give 1-(allyloxycarbonyl)pyrrolidin-3-yl isothiocyanate (896 mg, 83%) as a pale yellow oil. Ϫ4 mol) in a manner similar to that described above, in CH 2 Cl 2 (2 ml) was added N-(allyloxycarbonyl)pyrrolidin-3-yl isothiocyanate (188 mg, 8.88ϫ10
Allyl (8S,9R,10S)-5-[[N-(Allyloxycarbonyl)pyrrolidin-3-yl]thiocarbamoyl]-10-[(R)-1-(tert-butyldimethylsilyloxy
Ϫ4 mol) at room temperature. After being stirred for 1 h, the mixture was concentrated under reduced pres-sure. The residue was subjected to column chromatography on silica gel (10 g) using a mixture of EtOAc and hexane (1 : 1) as eluent and then HPLC using CHCl 3 as eluent to give 10p (280 mg, 77%) as a colorless viscous oil. Ϫ2 mol) in a mixture of 1 N NaOH (220 ml) and THF (100 ml) was added allyl chloroformate (11.6 ml, 1.10ϫ10 Ϫ2 mol) dropwise at 0°C. After being stirred for 2 h at room temperature, the mixture was saturated with NaCl and extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (125 g) using a mixture of EtOAc and MeOH (4 : 1) as eluent to give N-(allyloxycarbonyl)acetamidine (11.4 g, 73%) as a colorless oil. Ϫ3 mol) in a manner similar to that described above, in CH 2 Cl 2 (10 ml) was added N-(allyloxycarbonyl)acetamidine hydrochloride (530 mg, 2.97ϫ10 Ϫ3 mol) at 0°C. After being stirred at room temperature for 21 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NaHCO 3 and brine. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (40 g) using a mixture of EtOAc and hexane (2 : 3) as eluent to give 10r (121 mg, 12%) as a colorless viscous oil. Ϫ3 mol) in a manner similar to that described above, in THF (2 ml) was added a solution of N,NЈ-bis(allyloxycarbonyl)amidinopyrazole (334 mg, 1.20ϫ10 Ϫ3 mol) in THF (1 ml) at room temperature. After being stirred at the same temperature for 1 h, the mixture was diluted with EtOAc and washed with a saturated aqueous solution of NH 4 Cl and brine. The organic layer was dried and concentrated under reduced pressure. The crude product was subjected to column chromatography on silica gel (20 g) using a mixture of EtOAc and hexane (1 : 2) as eluent and then HPLC using CHCl 3 as eluent to give 10s (440 mg, 60%) as a colorless viscous oil. Ϫ3 mol), DMF (1 ml) and N-methylpyrrolidinone (NMP, 1 ml) was stirred at room temperature for 64 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (8 g) using a mixture of EtOAc and methanol (1 : 0 to 9 : 1) as eluent and then HPLC using CHCl 3 as eluent to give 11a (41.0 mg, 29%) as a colorless viscous oil.
1 H-NMR (CDCl 3 ) d: 1.31 (3H, d, Jϭ6.3 Hz), 1.45-1.70 (1H, m), 1.85-2.20 (2H,   m), 2.11, 2.16 (3H, sϫ2), 2.60-3.30 (2H, m), 3.27 (1H, dd, Jϭ6.4, 3.6 Ϫ4 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 7 d. The mixture was quenched with an aqueous solution of NaHCO 3 , saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (8 g) using a mixture of EtOAc and methanol (97 : 3 to 90 : 10) as eluent to give 11b (97.7 mg, 62%) as a colorless viscous oil. Ϫ3 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 72 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (8 g) using a mixture of EtOAc and methanol (95 : 5) as eluent and then HPLC using CHCl 3 as eluent to give 11c (79.0 mg, 50%) as a colorless viscous oil. Ϫ3 mol), DMF (3 ml) and NMP (3 ml) was stirred at room temperature for 72 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (18 g) using a mixture of EtOAc and methanol (95 : 5) as eluent and then HPLC using CHCl 3 as eluent to give 11d (262 mg, 59%) as a colorless viscous oil. Ϫ4 mol), NH 4 F · HF (45 mg, 7.9ϫ10 Ϫ4 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 70 h. An aqueous solution of NaHCO 3 was added to the mixture and extracted with a mixture of EtOAc and CH 2 Cl 2 (10 : 1). The extract was dried and concentrated under reduced pressure. The residue was subjected to HPLC using CHCl 3 as eluent to give 11f (98.0 mg, 54%) as a colorless viscous oil. 8S,9R,10S)-5-[(R)-1-Hydroxyethyl]-11-oxo-5-(3-pyridylcarbonyl)-1,5-diazatricyclo[7.2.0.0   3,8 ]undec-2-ene-2-carboxylate (11g) A mix-ture of 10g (200 mg, 5.13ϫ10 Ϫ4 mol), ammonium hydrogen fluoride (NH 4 F · HF, 45 mg, 7.9ϫ10 Ϫ4 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 7 d. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (6 g) using a mixture of EtOAc and methanol (1 : 0 to 8 : 2) as eluent to give 11g (85 mg, 54%) as a colorless viscous oil. 8S,9R,10S)-10-[(R)-1-Hydroxyethyl]-11-oxo-5-(4-pyridylcarbonyl)-1,5- mol), DMF (2 ml) and NMP (2 ml) was stirred at room temperature for 24 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (9 g) using a mixture of EtOAc and methanol (9 : 1) as eluent to give 11h (48 mg, 18%) as a colorless viscous oil. Ϫ3 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 3 d. The mixture was quenched with an aqueous solution of NaHCO 3 , saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (8 g) using a mixture of ethyl acetate and hexane (2 : 1 to 1 : 0) as eluent to give 11i (94.0 mg, 56%) as a colorless viscous oil. Ϫ4 mol), NH 4 F · HF (45 mg, 7.85ϫ10 Ϫ4 mol), DMF (0.5 ml) and NMP (0.5 ml) was stirred at room temperature for 47 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (9 g) using a mixture of EtOAc and methanol (4 : 1) as eluent and then HPLC using CHCl 3 as eluent to give 11j (31.0 mg, 39%) as a pale yellow viscous oil. Ϫ4 mol), NH 4 F · HF (106 mg, 1.85ϫ10 Ϫ3 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 46 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to HPLC using CHCl 3 as eluent to give 11k (39.0 mg, 24%) as a pale yellow viscous oil. ]undec-2-ene-2-carboxylate (11l) A mixture of 10l (115 mg, 2.56ϫ10 Ϫ4 mol), NH 4 F · HF (44 mg, 7.7ϫ10 Ϫ4 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 96 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (9 g) using a mixture of EtOAc and methanol (9 : 1) as eluent and then HPLC using CHCl 3 as eluent to give 11l (44.3 mg, 52%) as a colorless viscous oil. Ϫ3 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 43 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (9 g) using a mixture of EtOAc and hexane (4 : 1) as eluent and then HPLC using CHCl 3 as eluent to give 11m (48.0 mg, 41%) as a pale yellow viscous oil. Ϫ3 mol), DMF (1.2 ml) and NMP (1.2 ml) was stirred at room temperature for 48 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (9 g) using a mixture of EtOAc and methanol (1 : 0 to 9 : 1) as eluent and then HPLC using CHCl 3 as eluent to give 11n (45.2 mg, 24%) as a pale yellow viscous oil. Ϫ3 mol), DMF (1 ml) and NMP (1 ml) was stirred at room temperature for 30 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (9 g) using a mixture of EtOAc and methanol (1 : 0 to 95 : 5) as eluent and then HPLC using CHCl 3 as eluent to give 11o (59.8 mg, 40%) as a colorless viscous oil. Ϫ3 mol), DMF (1.25 ml) and NMP (1.25 ml) was stirred at room temperature for 48 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (3 g) using a mixture of EtOAc and methanol (9 : 1) as eluent and then HPLC using CHCl 3 as eluent to give 11p (137.5 mg, 67%) as a colorless viscous oil. 1 8S,9R,10S)-5-[N-(Allyloxycarbonyl)acetimidoyl]-10-[(R)-1-hydroxyethyl]-11-oxo-1,5- Ϫ4 mol), DMF (0.4 ml) and NMP (0.4 ml) was stirred at room temperature for 24 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (5 g) using a mixture of EtOAc and methanol (95 : 5) as eluent and then HPLC using CHCl 3 as eluent to give 11r (16. Ϫ3 mol), DMF (2 ml) and NMP (2 ml) was stirred at room temperature for 70 h. An aqueous solution of NaHCO 3 was added and the mixture was saturated with NaCl and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel (9 g) using a mixture of EtOAc, hexane and methanol (3 : 1 : 0 to 15 : 5 : 2) as eluent and then HPLC using CHCl 3 as eluent to give 11s (205 mg, 61%) as a colorless viscous oil. Ϫ4 mol), Pd (PPh 3 ) 4 (2.5 mg) and PPh 3 (2.8 mg) in EtOAc (1 ml) was added 0.5 M EtOAc solution of potassium 2-ethylhexanoate (0.22 ml) at room temperature and stirred for 10 min. Pale yellow precipitates that emerged were collected by filtration and washed with EtOAc. The crude solid thus obtained was purified by column chromatography on Cosmosil 75C 18 -PREP (10 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4a (29.5 mg, 80%) as a colorless powder. Ϫ4 mol), Pd(PPh 3 ) 4 (3 mg) and PPh 3 (3 mg) in a mixture of EtOAc and THF (1 : 1, 1.5 ml) was added dimedone (58 mg, 4.2ϫ10
Allyl (

Ϫ4 mol) at room temperature. After being stirred for 45 min, the precipitates that emerged were collected by filtration and washed with a mixture of THF and EtOAc. The crude solid thus obtained was subjected to column chromatography on Cosmosil 75C 18 -PREP (20 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4b (8.2 mg, 26%) as a colorless powder. Ϫ4 mol) and bis(triphenylphosphine)palladium dichloride (Pd(PPh 3 ) 2 Cl 2 , 5.4 mg) in CH 2 Cl 2 (1.5 ml) was added n-Bu 3 SnH (168 ml, 6.24ϫ10
Ϫ4 mol) at 0°C. After being stirred at room temperature for 15 min, hexane (5 ml) was added to the reaction mixture. Pale yellow precipitates that emerged were collected by filtration and washed with EtOAc. The crude solid thus obtained was purified by column chromatography on Cosmosil 75C 18 -PREP (10 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4c (31 mg, 61%) as a colorless powder. 8S,9R,10S)-10-[(R)-1-Hydroxyethyl]-5-[2-(N-methylamino)acetyl]-11-oxo-1,5-diazatricyclo[7.2.0.0   3,8 ]undec-2-ene-2-carboxylic Acid (4d) To a mixture of 11d (70.0 mg, 1.56ϫ10 Ϫ4 mol) and Pd(PPh 3 ) 2 Cl 2 (5.4 mg) in CH 2 Cl 2 (1.5 ml) was added n-Bu 3 SnH (168 ml, 6.24ϫ10
Ϫ4 mol) at 0°C. After being stirred at room temperature for 15 min, hexane was added to the reaction mixture. Pale yellow precipitates that emerged were collected by filtration and washed with EtOAc. The crude solid thus obtained was purified by column chromatography on Cosmosil 75C 18 -PREP (10 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4d (31 mg, 61%) as a colorless powder. Ϫ4 mol), CH 3 CN (1.3 ml) and phosphate buffer (pH 7.4, 1.3 ml) were added benzyl formimidate hydrochloride (439 mg, 2.55ϫ10 Ϫ3 mol) and N,N-diisopropylethylamine (270 ml, 1.55ϫ10 Ϫ3 mol) at 0°C. After being stirred for 1 h, water (5 ml) was added to the reaction mixture. The aqueous solution was washed with diethyl ether, and was concentrated under reduced pressure. The residue was purified by column chromatography on Cosmosil 75C 18 -PREP (12 ml) using water as eluent and then high pressure liquid chromatography on Cosmosil 5C 18 -AR (20 mm i.d.ϫ250 mm, Nacalai Tesque) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4e (5.3 mg, 13%) as a colorless powder. Ϫ4 mol) and Pd(PPh 3 ) 2 Cl 2 (2 mg) in CH 2 Cl 2 (4 ml) was added n-Bu 3 SnH (200 ml, 7.44ϫ10 Ϫ4 mol) at 0°C. After being stirred at room temperature for 15 min, hexane (8 ml) was added. Pale yellow precipitates that emerged were collected by filtration and washed with EtOAc. The crude solid thus obtained was purified by column chromatography on Cosmosil 75C 18 -PREP (10 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4f (31 mg, 61%) as a colorless powder. Ϫ4 mol), Pd(PPh 3 ) 4 (1.3 mg) and PPh 3 (1.5 mg) in EtOAc (0.5 ml) was added 0.5 M EtOAc solution of potassium 2-ethylhexanoate (0.24 ml) at room temperature and stirred for 30 min. Pale yellow precipitates that emerged were collected by filtration and washed with EtOAc. The crude solid thus obtained was purified by column chromatography on Cosmosil 75C 18 -PREP (20 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4g (29.2 mg, 65%) as a colorless powder. 8 (1H, m), 1.9-2.2 (1H, m), 3.14, 3.36 (1H, mϫ2), 3.2-3.4 (1H, m), 3.4-3.5 (1H, m) 4 (1.5 mg) and PPh 3 (1.7 mg) in EtOAc (0.5 ml) was added 0.5 M EtOAc solution of potassium 2-ethylhexanoate (0.27 ml) at room temperature and stirred for 20 min. Pale yellow precipitates that emerged were collected by filtration and washed with EtOAc. The crude solid thus obtained was purified by column chromatography on Cosmosil 75C 18 -PREP (20 ml) using water as eluent. Combined eluates were concentrated to ca. 10 Ϫ4 mol) at room temperature. After being stirred for 15 min, hexane was added to the reaction mixture. Pale yellow precipitates that emerged were collected by filtration and washed with hexane. The crude solid thus obtained was subjected to column chromatography on Cosmosil 75C 18 -PREP (10 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4i (21.4 mg, 38%) as a colorless powder. Ϫ5 mol) and Pd(PPh 3 ) 2 Cl 2 (4 mg) in CH 2 Cl 2 (0.3 ml) was added n-Bu 3 SnH (80 ml, 2.97ϫ10 Ϫ4 mol) at room temperature. After being stirred for 30 min, water (5 ml) was added to the reaction mixture. The mixture was washed with EtOAc and the aqueous layer was concentrated to ca. 1 ml under reduced pressure. The aqueous solution thus obtained was subjected to column chromatography on Cosmosil 75C 18 -PREP (5 ml) using water as eluent. Combined eluates were concentrated to ca. 5 ml under reduced pressure and then lyophilized to give 4j (16.6 mg, 64%) as a colorless powder. Ϫ5 mol) and Pd(PPh 3 ) 2 Cl 2 (0.7 mg) in CH 2 Cl 2 (1.5 ml) was added n-Bu 3 SnH (50 ml, 1.7ϫ10
Ϫ4 mol) at room temperature. After being stirred for 10 min, water (10 ml) and methanol (0.5 ml) were added to the reaction mixture. The mixture was washed with EtOAc and the aqueous phase was concentrated to ca. 1 ml under reduced pressure, and was subjected to column chromatography on Cosmosil 75C 18 -PREP (5 ml) using water as eluent. Combined eluates were concentrated to ca. 5 ml under reduced pressure and then lyophilized to give 4k (17.5 mg, 66%) as a colorless powder. Ϫ5 mol), Pd(PPh 3 ) 4 (1.5 mg) and PPh 3 (1.7 mg) in a mixture of THF, CH 2 Cl 2 and methanol (10 : 10 : 1, 2 ml) was added 0.5 M EtOAc solution of potassium 2-ethylhexanoate (170 ml) at room temperature and stirred for 15 min. Pale yellow precipitates that emerged were collected by filtration and washed with EtOAc. The crude solid thus obtained was purified by column chromatography on Cosmosil 75C 18 -PREP (10 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4l (29.2 mg, 65%) as a colorless ]undec-2-ene-2-carboxylic Acid (4m) To a mixture of 11m (47.0 mg, 1.02ϫ10 Ϫ4 mol) and Pd(PPh 3 ) 2 Cl 2 (4 mg) in CH 2 Cl 2 (0.5 ml) was added n-Bu 3 SnH (260 ml, 9.66ϫ10 Ϫ4 mol) at room temperature. After being stirred for 45 min, water (5 ml) was added to the reaction mixture. The mixture was washed with EtOAc and the aqueous phase was concentrated to ca. 1 ml under reduced pressure. The aqueous solution thus obtained was subjected to column chromatography on Cosmosil 75C 18 -PREP (5 ml) using a mixture of water and CH 3 CN (98 : 2) as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4m (6.1 mg, 18%) as a colorless powder. Ϫ4 mol) and Pd(PPh 3 ) 2 Cl 2 (1 mg) in CH 2 Cl 2 (1 ml) was added n-Bu 3 SnH (84 ml, 3.1ϫ10
Ϫ4 mol) at room temperature. After being stirred for 30 min, water (5 ml) was added to the reaction mixture. The mixture was washed with EtOAc and the aqueous phase was concentrated to ca. 1 ml under reduced pressure. The aqueous solution thus obtained was subjected to column chromatography on Cosmosil 75C 18 -PREP (5 ml) using a mixture of water and CH 3 CN (1 : 0 to 99 : 1) as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4n (12.6 mg, 44%) as a colorless powder. Ϫ3 mol) and N,N-diisopropylethylamine (210 ml, 1.21ϫ10 Ϫ3 mol) at 0°C. After being stirred for 30 min, water (5 ml) was added to the reaction mixture. The aqueous solution was washed with diethyl ether, and was concentrated under reduced pressure. The residue was purified by column chromatography on Cosmosil 75C 18 -PREP (10 ml) using water as eluent followed by HPLC on Cosmosil 5C 18 -AR (20 mm i.d.ϫ250 mm, Nacalai Tesque) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4q (17.6 mg, 27%) as a colorless powder. Ϫ5 mol) and Pd(PPh 3 ) 2 Cl 2 (2.4 mg) in CH 2 Cl 2 (0.3 ml) was added n-Bu 3 SnH (90 ml, 3.3ϫ10
Ϫ4 mol) at room temperature. After being stirred for 30 min, water (5 ml) was added. The mixture was washed with EtOAc and the aqueous phase was concentrated to ca. 1 ml under reduced pressure. The aqueous solution thus obtained was subjected to column chromatography on Cosmosil 75C 18 -PREP (5 ml) using water as eluent. Combined eluates were concentrated to ca. 10 ml under reduced pressure and then lyophilized to give 4r (8.4 mg, 45%) as a colorless powder. Ϫ4 mol) and Pd(PPh 3 ) 2 Cl 2 (5 mg) in CH 2 Cl 2 (7 ml) was added n-Bu 3 SnH (565 ml, 2.10ϫ10
Ϫ3 mol) at room temperature. After being stirred for 15 min, hexane was added to the reaction mixture. Pale yellow precipitates that emerged were collected by filtration and washed with hexane. The crude solid thus obtained was subjected to column chromatography on Cosmosil 75C 18 -PREP (20 ml) using water as eluent. Crystalline precipitates were emerged during concentration of the combined eluates under reduced pressure. The precipitates were collected by filtration and washed with cold water to give 4s (31 mg, 29%) as colorless crystals, mp 208°C (dec.). 
Measurement of Antibacterial Activity
MICs were measured on Nutrient agar (Eiken Chemical Ltd.) by the twofold dilution method. The inoculum size of the bacteria was one-loopful of 107 cfu/ml.
Determination of Urinary Recovery Urine was collected at 8 and 24 h after administration. Excretion as the parent 5-formimidoyl-5-azatrinem 4q was determined by bioassay using Bacillus subtilis ACTT6633. Urinary recovery (%, 0-24 h) was calculated based on the excretion and the initial dose.
